These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 10377236

  • 1. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.
    Zheng W, Nikulin VI, Konkar AA, Vansal SS, Shams G, Feller DR, Miller DD.
    J Med Chem; 1999 Jun 17; 42(12):2287-94. PubMed ID: 10377236
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
    Hicks A, McCafferty GP, Riedel E, Aiyar N, Pullen M, Evans C, Luce TD, Coatney RW, Rivera GC, Westfall TD, Hieble JP.
    J Pharmacol Exp Ther; 2007 Oct 17; 323(1):202-9. PubMed ID: 17626794
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.
    He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD.
    J Med Chem; 2000 Feb 24; 43(4):591-8. PubMed ID: 10691685
    [Abstract] [Full Text] [Related]

  • 7. Discovery of 1,7-cyclized indoles as a new class of potent and highly selective human beta3-adrenergic receptor agonists with high cell permeability.
    Mizuno K, Sawa M, Harada H, Taoka I, Yamashita H, Oue M, Tsujiuchi H, Arai Y, Suzuki S, Furutani Y, Kato S.
    Bioorg Med Chem; 2005 Feb 01; 13(3):855-68. PubMed ID: 15653351
    [Abstract] [Full Text] [Related]

  • 8. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.
    Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD, Feller DR.
    Chirality; 1994 Feb 01; 6(2):76-85. PubMed ID: 7911313
    [Abstract] [Full Text] [Related]

  • 9. Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.
    Nakajima Y, Hamashima H, Washizuka K, Tomishima Y, Ohtake H, Imamura E, Miura T, Kayakiri H, Kato M.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):251-4. PubMed ID: 15603933
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
    Fraundorfer PF, Fertel RH, Miller DD, Feller DR.
    J Pharmacol Exp Ther; 1994 Aug 17; 270(2):665-74. PubMed ID: 7915318
    [Abstract] [Full Text] [Related]

  • 11. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors.
    Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR.
    Pharmacology; 2001 Jan 17; 62(1):45-55. PubMed ID: 11150922
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.
    Mehta RC, Salazar-Bookaman MM, Fertel RH, De Los Angeles J, Nikulin VI, Fraundorfer PF, Miller DD, Feller DR.
    Biochem Pharmacol; 2000 Mar 01; 59(5):517-29. PubMed ID: 10660118
    [Abstract] [Full Text] [Related]

  • 14. Tryptamine-based human beta3-adrenergic receptor agonists. Part 2: SAR of the methylene derivatives.
    Sawa M, Tateishi H, Mizuno K, Harada H, Oue M, Tsujiuchi H, Furutani Y, Kato S.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):5963-6. PubMed ID: 15546708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T, Onda K, Hayakawa M, Matsui T, Takasu T, Ohta M.
    Eur J Med Chem; 2009 Jun 20; 44(6):2533-43. PubMed ID: 19232786
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K, Sawa M, Harada H, Tateishi H, Oue M, Tsujiuchi H, Furutani Y, Kato S.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):5959-62. PubMed ID: 15546707
    [Abstract] [Full Text] [Related]

  • 19. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE.
    J Pharmacol Exp Ther; 1999 Aug 20; 290(2):649-55. PubMed ID: 10411574
    [Abstract] [Full Text] [Related]

  • 20. Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.
    Fletcher DS, Candelore MR, Grujic D, Lowell BB, Luell S, Susulic VS, Macintyre DE.
    J Pharmacol Exp Ther; 1998 Nov 20; 287(2):720-4. PubMed ID: 9808702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.